CAREDX, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
CAREDX, INC. (CDNA) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$7.41 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-04.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2024-11-04
- CAREDX, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$7.41M.
- CAREDX, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$1.39M.
- CAREDX, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was -$16.66M.
- CAREDX, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-09-30 was -$23.48M.
- CAREDX, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$30.66M.
- CAREDX, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$18.71M.
- CAREDX, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$21.97M.
- CAREDX, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was -$46.78M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$7.41M 10-Q · filed 2024-11-04 | -$8.80M derived: sum of 2 quarters · filed 2024-11-04 | -$25.46M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | -$1.39M 10-Q · filed 2024-07-31 | -$18.05M 10-Q · filed 2024-07-31 | ||
| 2024-03-31 | -$16.66M 10-Q · filed 2024-05-09 | |||
| 2023-09-30 | -$23.48M 10-Q · filed 2024-11-04 | -$48.44M derived: sum of 2 quarters · filed 2024-11-04 | -$72.19M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | -$24.95M 10-Q · filed 2024-07-31 | -$48.70M 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | -$23.75M 10-Q · filed 2024-05-09 | |||
| 2022-09-30 | -$16.94M 10-Q · filed 2023-11-08 | -$38.64M derived: sum of 2 quarters · filed 2023-11-08 | -$58.28M 10-Q · filed 2023-11-08 | -$74.44M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$21.70M 10-Q · filed 2023-08-08 | -$41.34M 10-Q · filed 2023-08-08 | -$57.50M derived: sum of 3 quarters · filed 2023-08-08 | -$69.39M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$19.65M 10-Q · filed 2023-05-10 | -$35.80M derived: sum of 2 quarters · filed 2023-05-10 | -$47.70M derived: sum of 3 quarters · filed 2023-05-10 | -$49.62M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$16.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$28.05M derived: sum of 2 quarters · filed 2022-11-03 | -$29.98M derived: sum of 3 quarters · filed 2022-11-03 | -$30.66M 10-K · filed 2022-02-24 |
| 2021-09-30 | -$11.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$13.82M derived: sum of 2 quarters · filed 2022-11-03 | -$14.51M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$2.61M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$687.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$18.71M 10-K · filed 2022-02-24 | |||
| 2019-12-31 | -$4.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$6.59M derived: sum of 2 quarters · filed 2022-02-24 | -$14.44M derived: sum of 3 quarters · filed 2022-02-24 | -$21.97M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$1.81M 10-Q · filed 2019-10-31 | -$9.66M derived: sum of 2 quarters · filed 2019-10-31 | -$17.19M 10-Q · filed 2019-10-31 | -$20.95M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$7.85M 10-Q · filed 2019-10-31 | -$15.38M 10-Q · filed 2019-08-01 | -$19.13M derived: sum of 3 quarters · filed 2021-02-24 | -$39.10M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$7.53M 10-Q · filed 2019-10-31 | -$11.29M derived: sum of 2 quarters · filed 2021-02-24 | -$31.26M derived: sum of 3 quarters · filed 2021-02-24 | -$45.32M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$23.73M derived: sum of 2 quarters · filed 2021-02-24 | -$37.79M derived: sum of 3 quarters · filed 2021-02-24 | -$46.78M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$19.97M 10-Q · filed 2019-10-31 | -$34.03M derived: sum of 2 quarters · filed 2019-10-31 | -$43.03M 10-Q · filed 2019-10-31 | -$74.66M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$14.06M 10-Q · filed 2019-10-31 | -$23.06M 10-Q · filed 2019-08-01 | -$54.69M derived: sum of 3 quarters · filed 2020-02-28 | -$68.97M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$8.99M 10-Q · filed 2019-10-31 | -$40.62M derived: sum of 2 quarters · filed 2020-02-28 | -$54.91M derived: sum of 3 quarters · filed 2020-02-28 | -$58.95M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$31.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$45.92M derived: sum of 2 quarters · filed 2020-02-28 | -$49.95M derived: sum of 3 quarters · filed 2020-02-28 | -$55.56M 10-K · filed 2020-02-28 |
| 2017-09-30 | -$14.29M 10-Q · filed 2018-11-08 | -$18.32M derived: sum of 2 quarters · filed 2018-11-08 | -$23.93M 10-Q · filed 2018-11-08 | -$39.64M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | -$4.04M 10-Q · filed 2018-08-09 | -$9.64M 10-Q · filed 2018-08-09 | -$25.35M derived: sum of 3 quarters · filed 2019-03-06 | -$29.15M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | -$5.61M 10-Q · filed 2018-05-10 | -$21.32M derived: sum of 2 quarters · filed 2019-03-06 | -$25.12M derived: sum of 3 quarters · filed 2019-03-06 | -$35.61M derived: sum of 4 quarters · filed 2019-03-06 |
| 2016-12-31 | -$15.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$19.51M derived: sum of 2 quarters · filed 2019-03-06 | -$30.00M derived: sum of 3 quarters · filed 2019-03-06 | -$39.76M 10-K · filed 2019-03-06 |
| 2016-09-30 | -$3.80M 10-Q · filed 2017-11-09 | -$14.29M derived: sum of 2 quarters · filed 2017-11-09 | -$24.05M 10-Q · filed 2017-11-09 | -$28.81M derived: sum of 4 quarters · filed 2018-03-22 |
| 2016-06-30 | -$10.49M 10-Q · filed 2017-08-11 | -$20.25M 10-Q · filed 2017-08-11 | -$25.01M derived: sum of 3 quarters · filed 2018-03-22 | -$28.50M derived: sum of 4 quarters · filed 2018-03-22 |
| 2016-03-31 | -$9.75M 10-Q · filed 2017-06-09 | -$14.51M derived: sum of 2 quarters · filed 2018-03-22 | -$18.00M derived: sum of 3 quarters · filed 2018-03-22 | -$21.19M derived: sum of 4 quarters · filed 2018-03-22 |
| 2015-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | -$8.25M derived: sum of 2 quarters · filed 2018-03-22 | -$11.44M derived: sum of 3 quarters · filed 2018-03-22 | -$13.71M 10-K · filed 2018-03-22 |
| 2015-09-30 | -$3.49M 10-Q · filed 2016-11-14 | -$6.67M derived: sum of 2 quarters · filed 2016-11-14 | -$8.95M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -$3.19M 10-Q · filed 2016-08-22 | -$5.46M 10-Q · filed 2016-08-22 | ||
| 2014-12-31 | $781.00K 10-K · filed 2017-04-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |